Polyneuron Pharmaceuticals AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.polyneuron.com
First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy
- First Posted Date
- 2020-09-29
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Polyneuron Pharmaceuticals AG
- Target Recruit Count
- 1
- Registration Number
- NCT04568174
- Locations
- 🇨ðŸ‡
Lausanne, Lausanne, Switzerland
🇪🇸Barcelona, Barcelona, Spain
🇫🇷Service de Neurologie Centre de Référence Neuropathies Périphériques Rares, CHU Limoges, Limoges, France
© Copyright 2025. All Rights Reserved by MedPath